Bacil Pharma Limited (BACPHAR.BO)
INR 60.12
(-1.99%)
INR 60.12
(-1.99%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.87 Million INR | 5.95% |
| 2022 | 1.76 Million INR | 11.52% |
| 2021 | 1.58 Million INR | 15.96% |
| 2020 | 1.36 Million INR | -27.44% |
| 2019 | 1.88 Million INR | -28.38% |
| 2018 | 2.63 Million INR | -10.37% |
| 2017 | 2.93 Million INR | 70.92% |
| 2016 | 1.71 Million INR | 101.43% |
| 2015 | 853.02 Thousand INR | 70.51% |
| 2014 | 500.27 Thousand INR | -69.67% |
| 2013 | 1.64 Million INR | -9.39% |
| 2012 | 1.82 Million INR | 592.93% |
| 2011 | 262.66 Thousand INR | -48.26% |
| 2010 | 507.71 Thousand INR | 3.41% |
| 2009 | 490.96 Thousand INR | -16.36% |
| 2008 | 587 Thousand INR | 95.02% |
| 2007 | 301 Thousand INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 444 Thousand INR | -27.33% |
| 2024 Q2 | 729 Thousand INR | 63.29% |
| 2023 Q1 | 302 Thousand INR | -32.75% |
| 2023 Q4 | 611 Thousand INR | 7.57% |
| 2023 FY | 1.87 Million INR | 5.95% |
| 2023 Q2 | 404 Thousand INR | 33.77% |
| 2023 Q3 | 568 Thousand INR | 40.59% |
| 2022 Q1 | 429 Thousand INR | 402.93% |
| 2022 FY | 1.76 Million INR | 11.52% |
| 2022 Q2 | 424 Thousand INR | -1.17% |
| 2022 Q3 | 466 Thousand INR | 9.91% |
| 2022 Q4 | 449.06 Thousand INR | -3.64% |
| 2021 Q3 | 368 Thousand INR | -60.68% |
| 2021 Q1 | 290 Thousand INR | -86.27% |
| 2021 Q2 | 936 Thousand INR | 222.76% |
| 2021 Q4 | -141.61 Thousand INR | -138.48% |
| 2021 FY | 1.58 Million INR | 15.96% |
| 2020 FY | 1.36 Million INR | -27.44% |
| 2020 Q1 | 228 Thousand INR | 109.96% |
| 2020 Q2 | 312 Thousand INR | 36.84% |
| 2020 Q3 | 675 Thousand INR | 116.35% |
| 2020 Q4 | 2.11 Million INR | 212.89% |
| 2019 Q3 | 2.68 Million INR | 241.53% |
| 2019 Q2 | 785 Thousand INR | 10.72% |
| 2019 Q4 | -2.28 Million INR | -185.4% |
| 2019 FY | 1.88 Million INR | -28.38% |
| 2019 Q1 | 709 Thousand INR | 194.12% |
| 2018 Q1 | 1.17 Million INR | -0.09% |
| 2018 Q3 | 1.05 Million INR | -8.75% |
| 2018 Q2 | 1.15 Million INR | -1.54% |
| 2018 Q4 | -753.26 Thousand INR | -171.54% |
| 2018 FY | 2.63 Million INR | -10.37% |
| 2017 Q3 | 810 Thousand INR | -10.79% |
| 2017 Q1 | 533 Thousand INR | -21.62% |
| 2017 FY | 2.93 Million INR | 70.92% |
| 2017 Q4 | 1.17 Million INR | 44.81% |
| 2017 Q2 | 908 Thousand INR | 70.36% |
| 2016 Q1 | 452 Thousand INR | 1176.19% |
| 2016 Q2 | -79 Thousand INR | -117.48% |
| 2016 FY | 1.71 Million INR | 101.43% |
| 2016 Q4 | 680 Thousand INR | 1136.36% |
| 2016 Q3 | 55 Thousand INR | 169.62% |
| 2015 Q4 | -42 Thousand INR | -115.5% |
| 2015 FY | 853.02 Thousand INR | 70.51% |
| 2015 Q2 | 155 Thousand INR | -45.99% |
| 2015 Q1 | 287 Thousand INR | -57.85% |
| 2015 Q3 | 271 Thousand INR | 74.84% |
| 2014 Q4 | 680.82 Thousand INR | 1521.01% |
| 2014 FY | 500.27 Thousand INR | -69.67% |
| 2014 Q2 | 51 Thousand INR | -70.86% |
| 2014 Q1 | 175 Thousand INR | -84.69% |
| 2014 Q3 | 42 Thousand INR | -17.65% |
| 2013 Q4 | 1.14 Million INR | 746.81% |
| 2013 FY | 1.64 Million INR | -9.39% |
| 2013 Q2 | 92 Thousand INR | 87.76% |
| 2013 Q3 | 135 Thousand INR | 46.74% |
| 2013 Q1 | 49 Thousand INR | -92.59% |
| 2012 Q2 | 377 Thousand INR | -3.08% |
| 2012 Q1 | 389 Thousand INR | 63.67% |
| 2012 Q3 | 393 Thousand INR | 4.24% |
| 2012 Q4 | 661.11 Thousand INR | 68.22% |
| 2012 FY | 1.82 Million INR | 592.93% |
| 2011 Q4 | 237.66 Thousand INR | 316.06% |
| 2011 FY | 262.66 Thousand INR | -48.26% |
| 2011 Q3 | -110 Thousand INR | 0.0% |
| 2010 FY | 507.71 Thousand INR | 3.41% |
| 2009 FY | 490.96 Thousand INR | -16.36% |
| 2008 Q4 | 112 Thousand INR | 0.0% |
| 2008 FY | 587 Thousand INR | 95.02% |
| 2007 Q4 | 78 Thousand INR | 0.0% |
| 2007 FY | 301 Thousand INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 2.6 Million INR | 28.141% |
| KIMIA BIOSCIENCES LIMITED | 149.52 Million INR | 98.746% |
| SHELTER PHARMA LIMITED | 12.3 Million INR | 84.762% |
| Vasundhara Rasayans Limited | 145.5 Million INR | 98.712% |
| Sunil Healthcare Limited | 438.1 Million INR | 99.572% |
| Chemo Pharma Laboratories Limited | 1.94 Million INR | 3.729% |
| MedPlus Health Services Limited | 2.42 Billion INR | 99.923% |
| Bharat Immunologicals & Biologicals Corporation Limited | 184.08 Million INR | 98.982% |
| Patidar Buildcon Limited | 1.81 Million INR | -3.5% |
| Roopa Industries Limited | 24.63 Million INR | 92.391% |
| Smruthi Organics Limited | 261.73 Million INR | 99.284% |
| Trident Lifeline Limited | 46.87 Million INR | 96.001% |
| PANJON LTD. | 33.77 Million INR | 94.451% |
| Pharmaids Pharmaceuticals Limited | 76.49 Million INR | 97.55% |
| Gujarat Terce Laboratories Limited | 132.41 Million INR | 98.585% |
| TIAAN CONSUMER LIMITED | 107 Thousand INR | -1651.766% |
| Anuh Pharma Limited | 263.04 Million INR | 99.287% |
| Crestchem Limited | 50.8 Million INR | 96.31% |
| Emmessar Biotech & Nutrition Limited | 4.32 Million INR | 56.631% |
| Sandu Pharmaceuticals Limited | 212.9 Million INR | 99.12% |
| Tyche Industries Limited | 182.04 Million INR | 98.97% |
| Fredun Pharmaceuticals Limited | 360.45 Million INR | 99.48% |
| Trimurthi Limited | 4.81 Million INR | 61.039% |
| Shukra Pharmaceuticals Limited | 83.05 Million INR | 97.743% |
| Norris Medicines Limited | 18.2 Million INR | 89.704% |
| Zenlabs Ethica Limited | 57.89 Million INR | 96.762% |
| Vikram Thermo (India) Limited | 104.27 Million INR | 98.202% |
| ANG Lifesciences India Limited | 219.92 Million INR | 99.148% |
| Parmax Pharma Limited | 99.31 Million INR | 98.113% |
| Veerhealth Care Limited | 15.38 Million INR | 87.814% |
| Deccan Health Care Limited | 36.24 Million INR | 94.828% |
| SUDARSHAN PHARMA INDUSTRIES LI | 146.09 Million INR | 98.717% |
| Makers Laboratories Limited | 83.1 Million INR | 97.745% |
| Lactose (India) Limited | 111.66 Million INR | 98.321% |
| OXYGENTA PHARMACEUTICAL LIMITE | 23.78 Million INR | 92.118% |
| Zenith Healthcare Limited | 45.97 Million INR | 95.923% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 99.103% |
| PRAVEG LIMITED | 77.18 Million INR | 97.571% |
| Denis Chem Lab Limited | 453.36 Million INR | 99.587% |
| Kwality Pharmaceuticals Limited | 248.93 Million INR | 99.247% |
| Jenburkt Pharmaceuticals Limited | 437.2 Million INR | 99.571% |
| Colinz Laboratories Limited | 31.19 Million INR | 93.992% |
| Godavari Drugs Limited | 359.01 Million INR | 99.478% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.52 Million INR | -22.991% |
| Zenotech Laboratories Limited | 94.82 Million INR | 98.023% |
| Panchsheel Organics Limited | 68.15 Million INR | 97.25% |
| Shree Ganesh Remedies Limited | 104.13 Million INR | 98.2% |
| Vivanza Biosciences Limited | 4.55 Million INR | 58.85% |
| Phaarmasia Limited | 50.52 Million INR | 96.29% |
| Sastasundar Ventures Limited | 846.78 Million INR | 99.779% |
| Medi-Caps Limited | 93.11 Million INR | 97.987% |
| DECIPHER LABS LIMITED | 277.6 Million INR | 99.325% |
| Gujarat Themis Biosyn Limited | 156.84 Million INR | 98.805% |
| Ambalal Sarabhai Enterprises Limited | 280.83 Million INR | 99.333% |
| Mercury Laboratories Limited | 217.24 Million INR | 99.137% |
| Gennex Laboratories Limited | 130.37 Million INR | 98.562% |
| BDH Industries Limited | 57.03 Million INR | 96.713% |
| Coral Laboratories Limited | 189.75 Million INR | 99.012% |
| Concord Drugs Limited | 91.83 Million INR | 97.959% |
| Bharat Parenterals Limited | 255.97 Million INR | 99.268% |
| Beryl Drugs Limited | 93.77 Million INR | 98.001% |
| Vista Pharmaceuticals Limited | 20.16 Million INR | 90.705% |
| Evoq Remedies Limited | 4.51 Million INR | 58.504% |
| Add-Shop E-Retail Limited | 146.52 Million INR | 98.721% |
| Transchem Limited | 8.47 Million INR | 77.878% |
| Ishita Drugs and Industries Limited | 16.46 Million INR | 88.617% |
| Parnax Lab Limited | 80.59 Million INR | 97.674% |
| Source Natural Foods and Herbal Supplements Limited | 31.85 Million INR | 94.116% |
| Kerala Ayurveda Limited | 399.64 Million INR | 99.531% |
| Cian Healthcare Limited | 59.19 Million INR | 96.834% |
| Trinity League India Limited | -1.08 Million INR | 272.596% |
| Syschem (India) Limited | 64.13 Million INR | 97.077% |
| KOBO BIOTECH LIMITED | 2.48 Million INR | 24.42% |
| Natural Capsules Limited | 444.7 Million INR | 99.579% |
| Auro Laboratories Limited | 157.37 Million INR | 98.809% |